Antisense to Cyclin D1 Inhibits Vascular Endothelial Growth Factor–Stimulated Growth of Vascular Endothelial Cells: Implication of Tumor Vascularization
暂无分享,去创建一个
M. Monden | I. Weinstein | C. Ngan | Y. Fujio | I. Takemasa | M. Ikeda | M. Sekimoto | Makiko Maeda | N. Matsuura | Hirofumi Yamamoto | Y. Sugita | B. Damdinsuren | M. Yasui | H. Fukunaga | J. Gu | Jin-yu Gu
[1] M. Ko,et al. Identification of Zfp-57 as a downstream molecule of STAT3 and Oct-3/4 in embryonic stem cells. , 2005, Biochemical and biophysical research communications.
[2] Geng-yin Zhou,et al. Alteration of cyclin D1 in gastric carcinoma and its clinicopathologic significance. , 2004, World journal of gastroenterology.
[3] A. Bahnassy,et al. Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients , 2004, BMC gastroenterology.
[4] L. Favot,et al. Modulation of VEGF-induced endothelial cell cycle protein expression through cyclic AMP hydrolysis by PDE2 and PDE4 , 2004, Thrombosis and Haemostasis.
[5] J. Berlin,et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. , 2004, The New England journal of medicine.
[6] M. Monden,et al. Hepatic expression of ANG2 RNA in metastatic colorectal cancer , 2004, Hepatology.
[7] I. Kawase,et al. Hepatoma‐derived growth factor induces tumorigenesis in vivo through both direct angiogenic activity and induction of vascular endothelial growth factor , 2003, Cancer science.
[8] M. Monden,et al. JTE-522, a cyclooxygenase-2 inhibitor, is an effective chemopreventive agent against rat experimental liver fibrosis1. , 2003, Gastroenterology.
[9] J. Abbruzzese,et al. Stat3 activation regulates the expression of vascular endothelial growth factor and human pancreatic cancer angiogenesis and metastasis , 2003, Oncogene.
[10] M. Masuda,et al. Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma. , 2002, Cancer research.
[11] V. Sukhatme,et al. Endostatin Causes G1 Arrest of Endothelial Cells through Inhibition of Cyclin D1* , 2002, The Journal of Biological Chemistry.
[12] R. Busse,et al. Cytochrome P450 2C9-induced Endothelial Cell Proliferation Involves Induction of Mitogen-activated Protein (MAP) Kinase Phosphatase-1, Inhibition of the c-Jun N-terminal Kinase, and Up-regulation of Cyclin D1* , 2002, The Journal of Biological Chemistry.
[13] L. Ellis,et al. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis , 2002, Oncogene.
[14] J. Turkson,et al. Phosphotyrosyl Peptides Block Stat3-mediated DNA Binding Activity, Gene Regulation, and Cell Transformation* , 2001, The Journal of Biological Chemistry.
[15] I. Modlin,et al. Cyclin D1 Antisense Oligonucleotide Inhibits Cell Growth Stimulated by Epidermal Growth Factor and Induces Apoptosis of Gastric Cancer Cells , 2001, Japanese journal of cancer research : Gann.
[16] B. Bussolati,et al. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. , 2001, The American journal of pathology.
[17] S. Hirono,et al. Transduction of antisense cyclin D1 using two-step gene transfer inhibits the growth of rat hepatoma cells. , 2001, Cancer research.
[18] G. Clayman,et al. Antisense inhibition of cyclin D1 in human head and neck squamous cell carcinoma. , 2000, Archives of otolaryngology--head & neck surgery.
[19] M. Seto,et al. Cyclin D1 Expression Is Useful as a Prognostic Indicator for Advanced Esophageal Carcinomas, but Not for Superficial Tumors , 2000, Digestive Diseases and Sciences.
[20] I. Weinstein. Disorders in cell circuitry during multistage carcinogenesis: the role of homeostasis. , 2000, Carcinogenesis.
[21] M. Herlyn,et al. Antisense cyclin D1 induces apoptosis and tumor shrinkage in human squamous carcinomas. , 1999, Cancer research.
[22] M. Korc,et al. Inhibition of cyclin D1 expression in human pancreatic cancer cells is associated with increased chemosensitivity and decreased expression of multiple chemoresistance genes. , 1999, Cancer research.
[23] P. Zhou,et al. Antisense to cyclin D1 reverses the transformed phenotype of human gastric cancer cells. , 1999, World journal of gastroenterology.
[24] M. Mizumoto,et al. Predictive value of vascular endothelial growth factor (VEGF) in metastasis and prognosis of human colorectal cancer. , 1998, British Journal of Cancer.
[25] D. Gordon. Cyclin D1 regulates proliferation in pancreatic, colonic, and esophageal cancers , 1998 .
[26] Y. Oshika,et al. © 1998 Cancer Research Campaign , 2022 .
[27] M. Korc,et al. Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum. , 1998, The Journal of clinical investigation.
[28] Y. Doki,et al. Disorders in cell circuitry associated with multistage carcinogenesis: exploitable targets for cancer prevention and therapy. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[29] S. Gansauge,et al. Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis. , 1997, Cancer research.
[30] Y. Doki,et al. Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells. , 1997, Cancer research.
[31] A. Rustgi,et al. The targeting of the cyclin D1 oncogene by an Epstein-Barr virus promoter in transgenic mice causes dysplasia in the tongue, esophagus and forestomach , 1997, Oncogene.
[32] N. Ferrara,et al. The biology of vascular endothelial growth factor. , 1997, Endocrine reviews.
[33] I. Schieren,et al. Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells. , 1995, Oncogene.
[34] C. Sherr. G1 phase progression: Cycling on cue , 1994, Cell.
[35] Emma Lees,et al. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice , 1994, Nature.
[36] N. Nishida,et al. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. , 1994, Cancer research.
[37] Pengcheng Zhou,et al. Overexpression of cyclin D1 in rat fibroblasts causes abnormalities in growth control, cell cycle progression and gene expression. , 1993, Oncogene.
[38] H. Kleinman,et al. Role of the SIKVAV site of laminin in promotion of angiogenesis and tumor growth: an in vivo Matrigel model. , 1992, Journal of the National Cancer Institute.
[39] Yamamura Ken-ichi,et al. Efficient selection for high-expression transfectants with a novel eukaryotic vector , 1991 .
[40] H. Niwa,et al. Efficient selection for high-expression transfectants with a novel eukaryotic vector. , 1991, Gene.
[41] J. Folkman. What is the evidence that tumors are angiogenesis dependent? , 1990, Journal of the National Cancer Institute.
[42] J. Folkman. Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.
[43] K. Kinzler,et al. A simplified system for generating recombinant adenoviruses. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[44] G. Peters,et al. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. , 1996, Advances in cancer research.